Research Corporation Technologies Incorporated v. Eli Lilly and Company
Case Number:
4:16-cv-00191
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 25, 2026
9th Circ. Undoes $278M Eli Lilly Payment In Insulin Case
The Ninth Circuit ruled against a lower court Wednesday in saying pharmaceutical giant Eli Lilly does not owe $278 million in royalties to an Arizona company for insulin-brands sales, saying an agreement between the companies did not cover insulin products Eli Lilly made using a certain yeast expression technology.
-
October 20, 2021
Eli Lilly Must Pay Royalties In Diabetes Drug Row, Judge Says
A federal judge has determined that Eli Lilly owes an Arizona company a portion of the billions of dollars in sales from its insulin brands, citing a 1992 royalty agreement that allowed the pharmaceutical giant to use a certain strain of yeast to help develop the drugs.